DSigDB

Drug SIGnatures DataBase Collection of Annoated Drug / Compound Gene Sets

Home

Search Gene

Collection

Browse

Download

Help

DSigDB Home

Search Gene

Collections

Browse Gene Sets

Download

Help

Gene Set: D4 : CTD - Vanadium

---

Collection	D4 : CTD
Chemical Name	Vanadium ( From PubChem : VANADIUM )
FDA NPC WHO Indian Australia China Traditional Herbal Clinical Trail Not Not Not Not Not Not Not Not
Molecular Weight Hydrogen Bond Donor Count Hydrogen Bond Acceptor Count cLogP Lipinski Rule 50.9415 g/mol 0 0 0.0 True
Structure
InChI	InChI=1S/V
InChIKey	LEONUFNNVUYDNQ-UHFFFAOYSA-N
Links
Gene (149 / 159) ⊖ Less	Source Type Unit Value Gene PMID Assay Other CTD increases(expression) ABL1 D014639 CTD increases(activity) ACO1 D014639 CTD increases(expression) ADAM17 D014639 CTD decreases(expression) ADAMTS4 D014639 CTD affects(binding) AHR D014639 CTD decreases(reaction) AHR D014639 CTD decreases(expression) ALK D014639 CTD decreases(expression) AOC3 D014639 CTD affects(binding) ARNT D014639 CTD decreases(reaction) ARNT D014639 CTD decreases(expression) ATP1B4 D014639 CTD increases(expression) ATP2A3 D014639 CTD increases(expression) ATP2B1 D014639 CTD increases(expression) ATP2B2 D014639 CTD increases(expression) ATP5B D014639 CTD increases(expression) ATP5J2 D014639 CTD increases(expression) ATP5L D014639 CTD increases(expression) ATP5O D014639 CTD decreases(expression) ATP6AP1 D014639 CTD increases(expression) ATP6AP2 D014639 CTD decreases(expression) ATP6V0B D014639 CTD decreases(expression) ATP6V0C D014639 CTD increases(expression) ATP6V1A D014639 CTD decreases(expression) BMX D014639 CTD decreases(expression) BRAF D014639 CTD increases(expression) CACNA1F D014639 CTD increases(expression) CACNA2D2 D014639 CTD decreases(expression) CACNB1 D014639 CTD decreases(expression) CACNG4 D014639 CTD decreases(expression) CAMKK2 D014639 CTD decreases(expression) CCL16 D014639 CTD decreases(expression) CD36 D014639 CTD decreases(expression) CDK16 D014639 CTD decreases(expression) CDK17 D014639 CTD increases(expression) CDK6 D014639 CTD decreases(expression) CDK8 D014639 CTD increases(expression) CEACAM8 D014639 CTD increases(expression) CLU D014639 CTD decreases(expression) COL1A1 D014639 CTD decreases(expression) COL4A6 D014639 CTD decreases(expression) COL5A1 D014639 CTD decreases(expression) CSK D014639 CTD decreases(expression) CSNK1A1 D014639 CTD decreases(expression) CSNK2A2 D014639 CTD increases(activity) CUX1 D014639 CTD increases(expression) CXCL8 D014639 CTD increases(expression) CXCL8 D014639 CTD affects(binding) CYP1A1 D014639 CTD decreases(reaction) CYP1A1 D014639 CTD increases(activity) CYP1A1 D014639 CTD increases(expression) CYP1A1 D014639 CTD decreases(expression) CYP1A1 D014639 CTD decreases(expression) CYR61 D014639 CTD increases(expression) DGKB D014639 CTD decreases(expression) DGKG D014639 CTD increases(expression) DGKI D014639 CTD decreases(expression) DGKQ D014639 CTD increases(activity) ETV4 D014639 CTD decreases(expression) FGF17 D014639 CTD decreases(expression) FGFBP1 D014639 CTD increases(expression) FIGF D014639 CTD decreases(expression) GP1BB D014639 CTD decreases(expression) HGF D014639 CTD increases(activity) HIF1A D014639 CTD increases(expression) HIF1A D014639 CTD decreases(expression) ICAM4 D014639 CTD decreases(expression) IGFBP4 D014639 CTD increases(expression) IGFBP5 D014639 CTD increases(expression) IL6 D014639 CTD decreases(expression) INSIG1 D014639 CTD increases(expression) INSL4 D014639 CTD increases(expression) INSL5 D014639 CTD increases(activity) IRF1 D014639 CTD decreases(expression) ITGA10 D014639 CTD decreases(expression) ITGA3 D014639 CTD decreases(expression) ITGAX D014639 CTD increases(expression) ITGB7 D014639 CTD decreases(expression) JAK3 D014639 CTD decreases(expression) KCNA3 D014639 CTD decreases(expression) KCNC1 D014639 CTD increases(expression) KCNQ3 D014639 CTD decreases(expression) KCNQ4 D014639 CTD decreases(expression) KLF11 D014639 CTD affects(cotreatment) LITAF D014639 CTD increases(expression) LITAF D014639 CTD increases(expression) MAP2K6 D014639 CTD decreases(expression) MAP3K14 D014639 CTD increases(expression) MAP3K2 D014639 CTD decreases(expression) MAP3K4 D014639 CTD decreases(expression) MAP4K4 D014639 CTD increases(phosphorylation) MAPK1 D014639 CTD increases(phosphorylation) MAPK3 D014639 CTD increases(expression) MAPKAPK3 D014639 CTD increases(expression) MEGF8 D014639 CTD increases(expression) MFAP2 D014639 CTD decreases(expression) MMP1 D014639 CTD increases(expression) MMP14 D014639 CTD decreases(expression) MST1R D014639 CTD increases(expression) MUC5AC D014639 CTD increases(expression) NDRG1 D014639 CTD increases(activity) NEDD9 D014639 CTD increases(expression) NOS3 D014639 CTD increases(expression) NPY D014639 CTD decreases(expression) NRCAM D014639 CTD decreases(expression) P4HB D014639 CTD decreases(expression) PECAM1 D014639 CTD decreases(expression) PFKP D014639 CTD decreases(expression) PICK1 D014639 CTD increases(expression) PIK3R3 D014639 CTD decreases(expression) PKN1 D014639 CTD increases(expression) PLA2G2A D014639 CTD increases(expression) PLAU D014639 CTD decreases(expression) PRKACA D014639 CTD decreases(expression) PRKACG D014639 CTD decreases(expression) PRKCB D014639 CTD increases(expression) PRKCD D014639 CTD increases(expression) PRKCI D014639 CTD decreases(expression) PRKCQ D014639 CTD decreases(expression) PRKD1 D014639 CTD decreases(expression) PRKG1 D014639 CTD decreases(expression) PRKG2 D014639 CTD decreases(expression) PTK2B D014639 CTD decreases(expression) PTK6 D014639 CTD increases(expression) S1PR4 D014639 CTD increases(expression) SCN10A D014639 CTD increases(expression) SLC12A2 D014639 CTD decreases(expression) SLC12A7 D014639 CTD decreases(expression) SLC13A2 D014639 CTD increases(expression) SLC14A2 D014639 CTD decreases(expression) SLC15A1 D014639 CTD increases(expression) SLC16A5 D014639 CTD increases(expression) SLC17A5 D014639 CTD decreases(expression) SLC1A1 D014639 CTD decreases(expression) SLC1A4 D014639 CTD increases(expression) SLC22A14 D014639 CTD decreases(expression) SLC22A18AS D014639 CTD increases(expression) SLC23A1 D014639 CTD decreases(expression) SLC2A4 D014639 CTD decreases(expression) SLC30A3 D014639 CTD decreases(expression) SLC30A4 D014639 CTD decreases(expression) SLC31A1 D014639 CTD decreases(expression) SLC39A1 D014639 CTD decreases(expression) SLC6A9 D014639 CTD increases(expression) SLCO2B1 D014639 CTD decreases(expression) SLCO4A1 D014639 CTD decreases(expression) SMARCD1 D014639 CTD decreases(expression) STK17A D014639 CTD increases(expression) STK38 D014639 CTD increases(expression) TAP2 D014639 CTD decreases(expression) TBXAS1 D014639 CTD decreases(expression) TIAF1 D014639 CTD decreases(expression) TIMP1 D014639 CTD affects(cotreatment) TNF D014639 CTD increases(expression) TNF D014639 CTD increases(activity) TP53 D014639 CTD increases(expression) TROAP D014639 CTD increases(activity) USF1 D014639 CTD increases(expression) VDAC2 D014639 CTD decreases(expression) ZAP70 D014639
Download gene sets	gmt, text, Detailed text

Contact us
Tan Lab , Mail Stop 8117
12801 East 17th Avenue
Division of Medical Oncology , Department of Medicine
University of Colorado School of Medicine
Aurora, CO 80045, USA

* Best viewed in the latest version of Chrome (42+), Safari (8+), IE (11+) or Firefox (35+).